Digitalization Now
March 25, 2020
Digital technologies are here – but are they being used adequately?
1 min read
March 2020
From battling river blindness, to Ebola, to the threat of the coronavirus – March’s cover feature looks at how pharma is standing up to neglected tropical diseases and emerging pathogens. George Chressanthis explains why the coronavirus will have an economic impact on the pharma industry and what companies can do about it; and we catch up with new CEO, Stuart Young, about his change in role and the trends driving the business of clinical trials. In addition, Claudia Zylberberg makes the case for a regulatory framework for cell and gene ancillary materials; while the latest news, views and research, include a new polio vaccine, structure elucidation for natural products, and advice for budding entrepreneurs in the UK. We also sit down with “pharmaceutical nomad” and Chief Executive Officer at Bone Therapeutics, Miguel Forte.
A Word of Advice
March 24, 2020
Looking to set up your own company but lacking business acumen? Help is at hand
1 min read
What Lessons Have We Learned from Ebola?
March 24, 2020
And how can we ensure we are better prepared to develop new vaccines and treatments for future infectious disease outbreaks?
1 min read
Accepting Responsibility for Global Health
March 23, 2020
Morningside Pharmaceuticals, a UK company based in Leicestershire, develops generic medicines, but has also been supplying global aid for almost 30 years. The company works through the private sector, ministries of health, and with large aid agencies, such as UNICEF, WHO, MSF and the Red Cross. As a seasoned exporter of medical supplies to global aid organizations, Morningside demonstrates that pharmaceutical companies can make a big difference by donating drugs to the developing world. We speak with Nik Kotecha, CEO of Morningside, to discuss why pharma companies have a responsibility to take the lead.
1 min read
Regulate with the Times
March 21, 2020
Ancillary material quality has become critical to the clinical advancement of cell and gene therapies. We need a regulatory framework that ensures safety, while also recognizing the growing cost burden on suppliers
1 min read
Total Eradication
March 20, 2020
Will a new VLP-based polio vaccine help rid the world of the disease once and for all?
1 min read
Making Life a Little Bit Sweeter
March 19, 2020
Eliminating infectious diseases that lead to blindness in Africa – an eye-opening view from the frontlines
1 min read
Lending a Helping Hand
March 19, 2020
Maria Elena Bottazzi, Co-Director at the Texas Children’s Hospital Center for Vaccine Development at Baylor College of Medicine, and Bart Fryszczyn, a process development scientist at Merck, tell a tale of academia and industry – and how collaborations are essential to help the world’s poorest, who face some of the worst diseases.
1 min read
Natural Evolution of NMR Methodology?
March 18, 2020
How a new approach accurately determines the structure and stereochemistry of natural products that confound conventional methods
1 min read
The Need to be Seen
March 17, 2020
What is the current situation for rare diseases and orphan drug development?
1 min read
Changing the Clinical Trials Game
March 17, 2020
We catch up with a new CEO and his goals for a clinical trials business
1 min read
A Molecular Advantage
March 16, 2020
Using advanced diagnostics to develop and administer COVID-19 treatment
1 min read
A Green Pioneer
March 13, 2020
Celebrating a career dedicated to environmental protection
1 min read
Solid Vaccines for Liquid Tumors
March 13, 2020
Researcher at the Wyss Institute at Harvard University have developed a biomaterial-based vaccine that reportedly eliminates the deadly blood cancer, acute myeloid leukemia
1 min read
Manufacturing by Design
March 11, 2020
The gene therapy industry needs to reduce manufacturing costs by orders of magnitude. Let’s start by optimizing cell lines, improving transfectants, and optimizing downstream purification.
1 min read
Onward in Oncology: Lessons Learned with Carlo Toniatti
March 10, 2020
Carlo Toniatti takes us on a journey from the clinic, to academia, to industry – where he spent over two decades developing anti-cancer drugs – and shares his lessons learned along the way
1 min read
An Economic Infection
March 9, 2020
The coronavirus is likely to have an economic impact on the pharma industry and highlights the need for analytics to help predict future “black swan” events and mitigate their effects
1 min read
The Pharmaceutical Nomad
March 4, 2020
Sitting Down With... Miguel Forte, Chief Executive Officer at Bone Therapeutics, Belgium
1 min read
